AT7519, a cyclin-dependent kinase inhibitor, exerts its effects by transcriptional inhibition in leukemia cell lines and patient samples

Matthew S. Squires, Laurence Cooke, Victoria Lock, Wenqing Qi, E. Jonathan Lewis, Neil T. Thompson, John F. Lyons, Daruka Mahadevan

Research output: Contribution to journalArticlepeer-review

34 Scopus citations

Fingerprint

Dive into the research topics of 'AT7519, a cyclin-dependent kinase inhibitor, exerts its effects by transcriptional inhibition in leukemia cell lines and patient samples'. Together they form a unique fingerprint.

Medicine & Life Sciences